Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
about
The complement system: an evolution in progressComplement in disease: a defence system turning offensiveNew milestones ahead in complement-targeted therapy.Efficacy of Treatment of Non-hereditary Angioedema.Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures
P2860
Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
@en
type
label
Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
@en
prefLabel
Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
@en
P2860
P1476
Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
@en
P2093
Andrea Zanichelli
Marta Mansi
P2860
P356
10.1517/14656566.2016.1104300
P407
P577
2015-10-29T00:00:00Z